High-throughput NIS enhancer screening platform may be used to discover effective NIS enhancers, while K905-0266 TKI may serve as the potent NIS enhancer to treat thyroid cancers in combination with RAI. Here, SLC5A5 is linked to thyroid gland carcinoma.